Argus Reaffirms Hold Rating for CME Group (NASDAQ:CME)

CME Group (NASDAQ:CME)‘s stock had its “hold” rating reissued by investment analysts at Argus in a note issued to investors on Wednesday, Marketbeat reports.

Several other research firms also recently issued reports on CME. Raymond James Financial decreased their price objective on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. Barclays upped their target price on CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Bank of America lifted their price target on CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. TD Cowen boosted their price objective on CME Group from $305.00 to $328.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Finally, Morgan Stanley increased their price objective on CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $302.71.

CME Group Trading Down 1.0%

CME opened at $316.81 on Wednesday. The company has a market cap of $114.24 billion, a P/E ratio of 28.39, a PEG ratio of 3.72 and a beta of 0.24. CME Group has a one year low of $248.53 and a one year high of $329.16. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. The business’s 50-day simple moving average is $291.37 and its 200-day simple moving average is $277.29.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the firm earned $2.52 EPS. The company’s revenue was up 8.1% compared to the same quarter last year. As a group, equities research analysts expect that CME Group will post 10.49 EPS for the current fiscal year.

Insider Transactions at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Dennis Suskind sold 748 shares of the stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the transaction, the director directly owned 2,699 shares of the company’s stock, valued at $809,700. This represents a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,248 shares of company stock worth $8,355,450 over the last quarter. 0.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On CME Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in CME. Amundi increased its position in CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock worth $548,150,000 after purchasing an additional 385,225 shares in the last quarter. Truist Financial Corp grew its holdings in shares of CME Group by 8.9% during the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after buying an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC raised its position in shares of CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after buying an additional 13,512 shares during the last quarter. Elevate Capital Advisors LLC lifted its stake in shares of CME Group by 85.2% during the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after buying an additional 3,919 shares during the period. Finally, Victory Financial Group LLC boosted its position in CME Group by 310.2% during the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after acquiring an additional 2,302 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Jefferies raised its price target on CME to $356, an analyst upgrade that supports a higher valuation and likely contributed to recent buying and the stock reaching a new 1‑year high. Analyst upward revisions can lend momentum and justify higher multiples for CME. Jefferies Boosts CME Price Target
• Positive Sentiment: CME also hit a new one‑year high following that analyst upgrade, signaling strong near‑term demand and positive sentiment among investors. That price peak may have increased visibility and trading in the shares. CME Hits New 1‑Year High
• Neutral Sentiment: Argus reiterated a “hold” rating on CME, a neutral endorsement that neither materially changes the sell‑side narrative nor provides a clear catalyst for price movement. Argus Hold Reaffirmed
• Neutral Sentiment: Crypto market commentary points to a potential Bitcoin move toward $80k and references an unfilled CME gap; if realized, stronger crypto prices could lift CME’s crypto‑futures volumes, but this outcome is uncertain and timing is unclear. Investors should view this as a possible upside to derivatives volumes rather than a guaranteed driver. Bitcoin Signals $80K Target
• Neutral Sentiment: Short‑interest data published for early March shows anomalous values (reported as 0 shares and NaN increases). The figures appear erroneous or incomplete, so they should not be treated as evidence of increased bearish positioning until corrected data is released. (No reliable source link available in the entry.)

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.